Bhumsuk Keam

Bhumsuk Keam

UNVERIFIED PROFILE

Are you Bhumsuk Keam?   Register this Author

Register author
Bhumsuk Keam

Bhumsuk Keam

Publications by authors named "Bhumsuk Keam"

Are you Bhumsuk Keam?   Register this Author

100Publications

3370Reads

29Profile Views

Severe late dysphagia after multimodal treatment of stage III/IV laryngeal and hypopharyngeal cancer.

Jpn J Clin Oncol 2020 Feb;50(2):185-192

Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyz158DOI Listing
February 2020

Efficacy of a Decision Aid Consisting of a Video and Booklet on Advance Care Planning for Advanced Cancer Patients: Randomized Controlled Trial.

J Pain Symptom Manage 2019 Dec 20;58(6):940-948.e2. Epub 2019 Aug 20.

Department of Biomedical Science, Seoul National University College of Medicine, Seoul, South Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2019.07.032DOI Listing
December 2019

A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer.

Lung Cancer 2019 Oct 29;136:122-128. Epub 2019 Aug 29.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.08.031DOI Listing
October 2019

Clinical factors affecting progression-free survival with crizotinib in ALK-positive non-small cell lung cancer.

Korean J Intern Med 2019 Sep 29;34(5):1116-1124. Epub 2018 Jun 29.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2018.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718771PMC
September 2019

Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations.

J Thorac Oncol 2019 Sep 17;14(9):1556-1566. Epub 2019 May 17.

Seoul National University Cancer Research Institute, Seoul, Republic of Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.05.006DOI Listing
September 2019

First-line Pembrolizumab Versus Pembrolizumab Plus Chemotherapy Versus Chemotherapy Alone in Non-small-cell Lung Cancer: A Systematic Review and Network Meta-analysis.

Clin Lung Cancer 2019 09 11;20(5):331-338.e4. Epub 2019 May 11.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.05.009DOI Listing
September 2019

Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib.

Cancer Res Treat 2019 Jul 10;51(3):951-962. Epub 2018 Oct 10.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2018.0
Publisher Site
http://dx.doi.org/10.4143/crt.2018.052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639226PMC
July 2019

Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer.

Cancer Res Treat 2019 Jul 31;51(3):1231-1240. Epub 2018 Dec 31.

Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.486DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639241PMC
July 2019

Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer.

Clin Lung Cancer 2019 07 29;20(4):e442-e451. Epub 2019 Mar 29.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.03.005DOI Listing
July 2019

Safety and efficacy of immune checkpoint inhibitors for end-stage renal disease patients undergoing dialysis: a retrospective case series and literature review.

Invest New Drugs 2019 06 8;37(3):579-583. Epub 2018 Oct 8.

Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-018-0673-yDOI Listing
June 2019

NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors.

Cytotherapy 2019 Jun 20;21(6):603-611. Epub 2019 Apr 20.

Seoul National University Cancer Research Institute, Seoul, Republic of Korea; Department of Internal Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2019.03.312DOI Listing
June 2019

Pruritus in Patients Under Targeted Anticancer Therapy: A Multidimensional Analysis Using the 5-D Itch Scale.

Acta Derm Venereol 2019 Apr;99(4):435-441

Department of Dermatology, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2340/00015555-3129DOI Listing
April 2019

Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin.

J Clin Neurol 2019 Apr 11;15(2):259-261. Epub 2019 Mar 11.

Department of Neurology, Seoul National University, College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3988/jcn.2019.15.2.259DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444136PMC
April 2019

TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer.

Cancer Res Treat 2019 Jan 31;51(1):413-414. Epub 2018 Jul 31.

Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2018.335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333973PMC
January 2019

A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma.

Oncologist 2019 01 25;24(1):20-e29. Epub 2018 Sep 25.

Department of Internal Medicine, Seoul National University Hospital, Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0464DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324645PMC
January 2019

The Effect of Hospice Consultation on Aggressive Treatment of Lung Cancer.

Cancer Res Treat 2018 Jul 14;50(3):720-728. Epub 2017 Jul 14.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2017.169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056966PMC
July 2018

Generalization and representativeness of phase III immune checkpoint blockade trials in non-small cell lung cancer.

Thorac Cancer 2018 06 22;9(6):736-744. Epub 2018 Apr 22.

Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.12641DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456815PMC
June 2018

Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody.

Cancer Immunol Immunother 2018 Mar 4;67(3):459-470. Epub 2017 Dec 4.

Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, 82, Gumi-ro 173 beon-gil, Bundang-Gu, Seongnam, Gyeonggi-do, 13620, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-017-2092-xDOI Listing
March 2018

Repeat biopsy of patients with acquired resistance to EGFR TKIs: implications of biopsy-related factors on T790M mutation detection.

Eur Radiol 2018 Feb 7;28(2):861-868. Epub 2017 Aug 7.

Department of Radiology, Seoul National University College of Medicine, and Institute of Radiation Medicine, Seoul National University Medical Research Centre, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-017-5006-6DOI Listing
February 2018

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.

J Clin Oncol 2018 01 26;36(1):7-13. Epub 2017 Oct 26.

Vivek Subbiah and Maria E. Cabanillas, The University of Texas MD Anderson Cancer Center, Houston, TX; Robert J. Kreitman, National Institutes of Health, Bethesda, MD; Zev A. Wainberg, University of California Los Angeles, Los Angeles, CA; Jae Yong Cho, Yonsei University College of Medicine Gangnam Severance Hospital; Bhumsuk Keam, Seoul National University Hospital, Seoul, Republic of Korea; Jan H.M. Schellens, Netherlands Cancer Institute, Amsterdam; Jan H.M. Schellens, Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands; Jean Charles Soria, Institut Gustave Roussy, University of Paris-Sud, and University of Paris-Saclay, Villejuif, France; Patrick Y. Wen, Dana-Farber Cancer Institute, Boston, MA; Christoph Zielinski, Comprehensive Cancer Center, Medical University Vienna; Vienna, Austria; and Gladys Urbanowitz, Bijoyesh Mookerjee, Dazhe Wang, and Fatima Rangwala, Novartis Oncology, East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.6785DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791845PMC
January 2018

Clonal History and Genetic Predictors of Transformation Into Small-Cell Carcinomas From Lung Adenocarcinomas.

J Clin Oncol 2017 Sep 12;35(26):3065-3074. Epub 2017 May 12.

June-Koo Lee, Jeonghwan Youk, Seongyeol Park, Yohan An, Joon Kim, Young Seok Ju, Korea Advanced Institute of Science and Technology; Junehawk Lee, Korea Institute of Science and Technology Information, Daejeon; Sehui Kim, Bhumsuk Keam, Dong-Wan Kim, Dae Seog Heo, Young Tae Kim, Yoon Kyung Jeon, Doo Hyun Chung, Tae Min Kim, Seoul National University Hospital; Soyeon Kim, Bhumsuk Keam, Dong-Wan Kim, Dae Seog Heo, Young Tae Kim, Ja-Lok Ku, Yoon Kyung Jeon, Tae Min Kim, Seoul National University Cancer Research Institute; Jin-Soo Kim, Seoul Metropolitan Government-Seoul National University Boramae Medical Center; Se-Hoon Lee, Keunchil Park, Sungkyunkwan University School of Medicine; Doo Hyun Chung, Seoul National University College of Medicine, Seoul; Se Hyun Kim, Jong Seok Lee, Seoul National University Bundang Hospital, Seongnam, Republic of Korea; and Peter J. Park, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.9096DOI Listing
September 2017

Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.

Clin Lung Cancer 2017 05 28;18(3):e169-e178. Epub 2016 Dec 28.

Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.12.013DOI Listing
May 2017

Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.

Am J Pathol 2017 May 9;187(5):980-986. Epub 2017 Mar 9.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2017.01.004DOI Listing
May 2017

KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer.

Korean J Intern Med 2017 May 14;32(3):514-522. Epub 2017 Apr 14.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2015.299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432792PMC
May 2017

Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer.

Cancer Res Treat 2017 Apr 28;49(2):416-422. Epub 2016 Jul 28.

Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2016.121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398400PMC
April 2017

Implication of Tumor Location for Lymph Node Metastasis in Maxillary Sinus Carcinoma: Indications for Elective Neck Treatment.

J Oral Maxillofac Surg 2017 Apr 13;75(4):858-866. Epub 2016 Oct 13.

Professor, Department of Radiation Oncology, Cancer Research Institute, and Institute of Radiation Medicine, Medical Research Center, Seoul National University College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2016.10.004DOI Listing
April 2017

Reply to Influenza vaccination in patients with cancer.

Cancer 2017 04 9;123(7):1273. Epub 2017 Feb 9.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30611DOI Listing
April 2017

Comparative analysis of PD-L1 expression between primary and metastatic pulmonary adenocarcinomas.

Eur J Cancer 2017 04 20;75:141-149. Epub 2017 Feb 20.

Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.01.004DOI Listing
April 2017

MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.

Lung Cancer 2017 04 16;106:131-137. Epub 2017 Feb 16.

Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.02.008DOI Listing
April 2017

Prognostic Impact of Newly Proposed M Descriptors in TNM Classification of Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 03 17;12(3):520-528. Epub 2016 Nov 17.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.11.2216DOI Listing
March 2017

Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cycles.

Cancer 2017 Mar 20;123(5):841-848. Epub 2016 Dec 20.

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30468DOI Listing
March 2017

Optimal design and endpoint of clinical trials using immune checkpoint blocking agents.

Expert Rev Anticancer Ther 2016 12 28;16(12):1217-1218. Epub 2016 Oct 28.

c National Cancer Center , Goyang , Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2016.1248945DOI Listing
December 2016

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort.

J Clin Oncol 2016 11 30;34(32):3838-3845. Epub 2016 Sep 30.

Laura Q.M. Chow, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Robert Haddad, Dana-Farber Cancer Institute, Boston, MA; Shilpa Gupta and Amit Mahipal, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Ranee Mehra, Fox Chase Cancer Center, Philadelphia, PA; Joseph Paul Eder and Barbara Burtness, Yale University Cancer Center, New Haven, CT; Hyunseok Kang, Johns Hopkins University, Baltimore, MD; Jared Weiss, Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, NC; Amy Meister, Marisa Dolled-Filhart, Kumudu Pathiraja, and Jonathan D. Cheng, Merck, Kenilworth, NJ; Tanguy Y. Seiwert, The University of Chicago, Chicago, IL; Makoto Tahara, National Cancer Center Hospital East, Kashiwa; Kei Muro, Aichi Cancer Center Hospital, Nagoya, Japan; Raanan Berger, Sheba Medical Center, Tel Hashomer; Ravit Geva, Sourasky Medical Center, Tel-Aviv, Israel; Se-Hoon Lee and Bhumsuk Keam, Seoul National University Hospital; Hyun Cheol Chung, Yonsei University College of Medicine, Seoul, Korea; and Chia-Chi Lin, National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804896PMC
November 2016

Prognostic implications of and status in esophageal squamous cell carcinoma.

World J Gastroenterol 2016 Nov;22(44):9803-9812

Dohee Kwon, Ji Yun Yun, Yoon Kyung Jeon, Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i44.9803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124985PMC
November 2016

Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma.

World J Gastroenterol 2016 Oct;22(37):8389-8397

Ryul Kim, Chan-Young Ock, Miso Kim, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v22.i37.8389DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055869PMC
October 2016

Change in PD-L1 Expression After Acquiring Resistance to Gefitinib in EGFR-Mutant Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2016 07 1;17(4):263-270.e2. Epub 2015 Dec 1.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304150027
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2015.11.006DOI Listing
July 2016

Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.

Clin Lung Cancer 2016 07 30;17(4):245-252.e1. Epub 2015 Nov 30.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.11.012DOI Listing
July 2016

Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions.

Int J Mol Sci 2016 Jul 5;17(7). Epub 2016 Jul 5.

Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms17071074DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964450PMC
July 2016

Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.

Mol Cancer Ther 2016 06 16;15(6):1387-96. Epub 2016 Feb 16.

Tumor Immunity Medical Research Center, Cancer Research Center, Seoul National University College of Medicine, Seoul, South Korea. Tumor Microenvironment Global Core Research Center, Seoul National University, Seoul, South Korea. Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0089DOI Listing
June 2016

Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration.

Clin Cancer Res 2016 05 27;22(9):2261-70. Epub 2016 Jan 27.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-2834DOI Listing
May 2016

WITHDRAWN:Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure.

Korean J Intern Med 2016 Apr 21. Epub 2016 Apr 21.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2014.259DOI Listing
April 2016

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

J Cancer Res Clin Oncol 2016 Mar 18;142(3):707-14. Epub 2015 Nov 18.

Cancer Research Institute, Seoul National University College of Medicine, 101 Daehakro, Jongro-gu, Seoul, 110-799, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-015-2072-5DOI Listing
March 2016

Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors.

Cancer Immunol Res 2016 Mar 19;4(3):215-24. Epub 2016 Jan 19.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0118DOI Listing
March 2016

Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors.

Thorac Cancer 2016 03 28;7(2):161-6. Epub 2015 Aug 28.

Department of Internal Medicine Seoul National University Hospital Seoul Korea; Cancer Research Institute Seoul National University College of Medicine Seoul Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.12304DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773306PMC
March 2016

EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3.

Oncoimmunology 2016 Mar 29;5(3):e1108514. Epub 2015 Oct 29.

Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea; Ischemic/Hypoxia Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1108514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839370PMC
March 2016

MET amplification, protein expression, and mutations in pulmonary adenocarcinoma.

Lung Cancer 2015 Dec 27;90(3):381-7. Epub 2015 Oct 27.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.10.022DOI Listing
December 2015

Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure.

Korean J Intern Med 2015 Nov 30;30(6):891-8. Epub 2015 Oct 30.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3904/kjim.2015.30.6.891DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642019PMC
November 2015